The Effect of Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive Functions After Carotid Endarterectomy
NCT ID: NCT05652426
Last Updated: 2022-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6 participants
OBSERVATIONAL
2021-01-01
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: In this retrospective study, patients who were scheduled for carotid endarterectomy, examined the MOCA tests before and after the operation and collected blood samples intraoperatively were included between January 2020-2021. The time periods specified below, blood samples were taken and serums were frozen at -80 celcius all this patients. Montreal cognitive function assessment test was applied before the operation, 24 hours and 7 days after the operation. Ten mililiters venous blood samples were collected to examine the status of basal neuron specific enolase, S100B, oxydative stress parameters (HAF-1 and DAF-1) at time intervals. Time intervals as follow:
T1: Peripheral baseline measurements (blood will be taken from arterial blood sampling) + Cerebral Oxymeter levels + Montreal cognitive performance test + Modified Rankin Scale (mRS) T2: 1 minute before clamping (from peripheral and jugular vena blood sampling) + Cerebral Oxymeter levels T3: Before opening clamp(from peripheral and jugular vena blood sampling) + Cerebral Oxymeter levels T4: 24 hours after the procedure. (peripheral blood sampling) + Montreal cognitive performance test T5: 7 days after the operation. (peripheral blood sampling) + Montreal cognitive performance test + CO levels+ Modified Rankin Scale (mRS) Results: We found significantly positive corelation between cerebral oxymeter levels, oxydative stress parameters and cognitive performance tests in this six patient.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
T1: Peripheral baseline measurements (blood will be taken from arterial blood sampling) + Cerebral Oxymeter levels + MoCA + Modified Rankin Scale (mRS) T2: 1 minute before clamping (from peripheral and jugular vena blood sampling) + Cerebral Oxymeter levels T3: Before opening clamp(from peripheral and jugular vena blood sampling) + Cerebral Oxymeter levels T4: 24 hours after the procedure. (peripheral blood sampling) + MoCA test T5: 7 days after the operation. (peripheral blood sampling) + MoCA + CO levels+ Modified Rankin Scale The degree of stenosis was determined according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. Written informed consent form was obtained from the patients 1 day before the operation. Basal invasive arterial blood pressure, pulse oximetry, heart rate, cerebral perfusion pressure, cerebral oximetry levels records of all patients were taken as baseline values before the operation. During the operation, serum samples were taken and 5 ml blood samples were taken from the artery (peripheral) and 5 ml from the vena jugularis interna during the operation. Blood samples were immediately centrifuged at 15000 rpm for 15 minutes and the supernatant was collected. The supernatant was immediately stored at -80 °C for further analysis of oxidative stress and other parameters. The parameters studied are: Human NSE(Neuron Specific Enolase) ELISA Kit, Neuron Specific Enolase ELISA Kit, Human S100B (S100 Calcium Binding Protein B) ELISA Kit, HIF-1α (Hypoxia Inducible Factor 1 Alpha) ELISA Kit, Human DAF(Decay Accelerating Factor) ELISA Kit.
A. General anesthesia procedure: Anesthesia induction was performed with 1-2 mg/kg propofol, 1 mcg/kg fentanyl, 0.5 mg/kg rocuronium. Anesthesia was maintained with remifentanil infusion (0.05-0.1 mcg/kg/min), 1-2% sevoflurane (1 MAC), and rocuronium. Mechanical ventilation parameters were adjusted to be within the limits of end-tidal carbon dioxide normocarby (35-45mm Hg) (mean 40 mmHg). To prevent the development of bradycardia, 1% lidocaine was applied to the internal, external and common carotid arteries by the surgical team. Following systemic intravenous (5000 IU) heparin administration, carotid arterial cross-clamp was placed with appropriate active clotting time (\>200) B. Superficial and deep cervical blockade: It was done with 0.5% isobaric bupivacaine 15 ml + 2% prilocaine 5 ml.
ΔrSO2 (%) = 100 x (rSO2preclamping - rSO2baseline) / rSO2baseline Baseline rSO2 value, rSO2 measurement for each specific time point and %rSO2 change between them were continuously monitored by oximetry (Invos System 4100, Somonetics Corporation, Troy, MI, USA). The entire CEA surgical procedure was performed with the standardized technique in these 6 patients.
In the analysis phase, the patients were evaluated in 2 groups. Group 1: Basal cerebral oximetry levels between 41-60% Group 2: Basal cerebral oximetry levels \> 61%
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Basal cerebral oximetry levels between 41-60%
No interventions assigned to this group
Group 2
Basal cerebral oximetry levels \> 61%
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Acute or chronic renal failure
* Liver failure
* History of previous carotid or brain trauma
* Vasculitis
* Thyroid diseases
* Adrenal insufficiency
* Patients who cannot perform cognitive function tests
* Anemia (below 10 g/dl)
* History of previous stroke in the last 6 months
* Patients with plegia in the dominant upper extremity
* Patients who will be shunted during the operation.
* Patients with vertebrobacillary arterial system or ring of Willis anomaly
* Presence of acute myocardial infarction.
* Traumatic brain injuries less than 6 months before the study.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duzce University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İlknur S Yorulmaz
Role: PRINCIPAL_INVESTIGATOR
Duzce University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
İlknur Suidiye Yorulmaz
Düzce, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, Todd GJ, McCormick PC, McMurtry JG, Quest DO, Stern Y, Lazar RM, Connolly ES. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol. 2002 Feb;59(2):217-22. doi: 10.1001/archneur.59.2.217.
Zhang HP, Ma XD, Chen LF, Yang Y, Xu BN, Zhou DB. Cognitive Function After Carotid Endarterectomy: Early Decline and Later Recovery. Turk Neurosurg. 2016;26(6):833-839. doi: 10.5137/1019-5149.JTN.13382-14.1.
Kuzhuget R, Starodubtsev V, Ignatenko P, Starodubtseva A, Voroshilina O, Ruzankin P, Karpenko A. The role of stump pressure and cerebral oximetry in predicting ischaemic brain damage during carotid endarterectomy. Brain Inj. 2017;31(13-14):1944-1950. doi: 10.1080/02699052.2017.1347279. Epub 2017 Sep 5.
Koh MY, Powis G. Passing the baton: the HIF switch. Trends Biochem Sci. 2012 Sep;37(9):364-72. doi: 10.1016/j.tibs.2012.06.004. Epub 2012 Jul 18.
Schmid T, Zhou J, Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med. 2004 Oct-Dec;8(4):423-31. doi: 10.1111/j.1582-4934.2004.tb00467.x.
Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004 Feb 29;36(1):1-12. doi: 10.1038/emm.2004.1.
Hashimoto T, Shibasaki F. Hypoxia-inducible factor as an angiogenic master switch. Front Pediatr. 2015 Apr 24;3:33. doi: 10.3389/fped.2015.00033. eCollection 2015.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISuidiye
Identifier Type: -
Identifier Source: org_study_id